inclisiran

FDA approves label update of Novartis’ Leqvio to treat high LDL-C
Pharmaceutical Business Review
Tue, 07/11/23 - 10:20 am
Novartis
Leqvio
inclisiran
LDL-C
It Was To Be The Cholesterol Drug For The Masses. Novartis Changed That.
Forbes
Mon, 01/3/22 - 10:42 am
Novartis
inclisiran
Leqvio
cholesterol
Novartis looks to manufacturing investment to drive down cost of siRNA drug
Biopharma Reporter
Mon, 08/9/21 - 11:01 am
Novartis
Leqvio
drug manufacturing
siRNA
inclisiran
Novartis eyes New Year verdict from FDA on delayed Leqvio
Pharmaforum
Wed, 07/21/21 - 10:58 am
Novartis
FDA
Leqvio
inclisiran
Novartis to make Leqvio for U.S. in Austria to overcome FDA delay
Reuters
Tue, 07/6/21 - 11:04 am
Novartis
Leqvio
inclisiran
drug manufacturing
FDA
Austria
Novartis' Q4 earnings clouded by regulatory setbacks on inclisiran, Zolgensma
Endpoints
Tue, 01/26/21 - 11:30 am
Novartis
earnings
inclisiran
Zolgensma
FDA Refuses to Approve Novartis' $9.7 Billion Cholesterol Drug for Now
Motley Fool
Sat, 12/19/20 - 11:41 pm
Novartis
FDA
cholesterol
inclisiran
complete response letter
Novartis’ $9.7B PCSK9 drug nabs first OK — now comes the challenge of finding a market
Endpoints
Fri, 12/11/20 - 11:06 am
Europe
Novartis
PCSK9
inclisiran
Regeneron flashes ‘great advance' in the NEJM for that other cholesterol drug sitting at the FDA
Endpoints
Wed, 08/19/20 - 11:45 pm
Regeneron
inclisiran
RNAi
Novartis
New England Journal of Medicine
Go or no go? Valuable drugs set for FDA decisions
EP Vantage
Wed, 07/29/20 - 10:54 am
FDA
drug approvals
Novartis
inclisiran
Biomarin
valrox
Roche
risdiplam
GSK
belantamab mafodotin
Gilead Sciences
Galapagos
filgotinib
ACC: New owner Novartis presents pooled inclisiran data cutting LDL cholesterol by half
Fierce Biotech
Sat, 03/28/20 - 11:43 pm
Novartis
ACC
PCSK9 inhibitors
inclisiran
Novartis posts pivotal data ahead of FDA decision on $9.7B bet
Fierce Biotech
Thu, 03/19/20 - 11:04 am
Novartis
inclisiran
clinical trials
FDA
Blockbusters in waiting: drug launches to watch in 2020
Pharmaforum
Mon, 02/17/20 - 11:33 pm
drug launches
Biohaven
rimegepant
Novartis
ofatumumab
Celgene
ozanimod
Akebia Therapeutics
vadadustat
Biomarin
valrox
Gilead Sciences
filgotinib
Novo Nordisk
oral semaglutide
inclisiran
Immunomedics
sacituzumab govitecan
AstraZeneca
Enhertu
Bristol-Myers Squibb
liso-cel
Novartis plots cardio trial in UK as London HQ opens
Pharmaforum
Wed, 02/12/20 - 10:52 am
Novartis
clinical trials
London
UK
inclisiran
Why Novartis's $9.7 Billion Purchase of The Medicines Company Is Bad News for Amgen
Motley Fool
Mon, 12/2/19 - 11:59 pm
Novartis
Medicines Company
M&A
inclisiran
Why Novartis Is Buying The Medicines Company For $9.7 Billion
Forbes
Tue, 11/26/19 - 09:44 am
Novartis
Medicines Company
M&A
inclisiran
Amidst Novartis Takeover Rumors, The Medicines Company Announces Positive Cholesterol Data
BioSpace
Tue, 11/19/19 - 11:32 pm
The Medicines Company
Novartis
M&A
inclisiran
clinical trials
AHA: MedCo's PCSK9 rival inclisiran hits LDL
Fierce Biotech
Mon, 11/18/19 - 09:53 am
AHA
The Medicines Company
inclisiran
The Medicines Company Surges on Positive Drug Trial Results
Motley Fool
Tue, 10/1/19 - 10:54 pm
Medicines Company
inclisiran
clinical trials
MedCo Preps for FDA Filing as Cholesterol Drug Clears Last Two Tests
Xconomy
Wed, 09/25/19 - 11:53 am
The Medicines Company
clinical trials
inclisiran
cholesterol

Pages